New cholesterol drug HRS-1301 enters Mid-Stage trial
NCT ID NCT07229937
First seen Nov 17, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tests a new medicine called HRS-1301 for people with high cholesterol (dyslipidemia). About 189 adults will receive either the drug or a placebo for 12 weeks to see how well it lowers bad cholesterol and if it is safe. The goal is to find the best dose for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The 2nd Affiliated Hospital of Harbin
RECRUITINGHarbin, Heilongjiang, 150086, China
Contact
Conditions
Explore the condition pages connected to this study.